You are here

AN IMPROVED QLS INSTRUMENT TO MONITOR EARLY CATARACT

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: N/A
Agency Tracking Number: 7260
Amount: $294,357.00
Phase: Phase II
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Timeline
Solicitation Year: N/A
Award Year: 1989
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
22 East Broadway
Gardner, MA 01440
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 Peter C Magnante Phd
 (617) 630-1800
Business Contact
Phone: () -
Research Institution
N/A
Abstract

QUASI-ELASTIC LIGHT SCATTERING (QLS) HAS BEEN USED TO NONINVASIVELY DETECT AND QUANTIFY THE MOLECULAR CHANGES ASSOCIATED WITH THE EARLY STAGES OF CATARACT FORMATION IN THE LIVING HUMAN LENS. IT IS PROPOSED TO DEVELOP A COMMERCIAL QLS INSTRUMENT. TO ESTABLISH FEASIBILITY, SPECIFIC IMPROVEMENTS WILL BE MADE TO AN EXISTING PROTOTYPE. THE IMPROVEMENTS INCLUDE: (1) BETTER MEASUREMENTLOCALIZATION ACCURACY, (2) REDUCED MEASUREMENT TIME, (3) UTILIZATION OF A CALIBRATION STANDARD, (4) EASY-TO-INTERPRETMEASUREMENT RESULTS BASED ON A UNIVERSAL LINEAR CATARACT-GRADING SCALE, AND (5) USE OF A SIMPLER AND LESS EXPENSIVE SIGNAL PROCESSOR. MANY COMMERCIAL APPLICATIONS EXIST FOR AN INSTRUMENT THAT PROVIDES A RELIABLE, NONINVASIVE MEASUREMENT OF EARLY CATARACTOGENESIS IN VIVO. TO PROVIDE SUCH A MEASUREMENT CAPABILITY HAS LONG BEEN AN IMPORTANT GOAL IN HUMAN CLINICALCATARACT RESEARCH. SUCH AN INSTRUMENT IS NEEDED FOR THE FOLLOWING PURPOSES: (1) TO ASSESS THE EFFECTIVENESS OF PUTATIVE ANTICATARACT REAGENTS, (2) TO EVALUATE THE CATARACTOGENIC ROLE OF PHARMACOLOGIC AGENTS OR RADIATION USED IN THE TREATMENT OF SYSTEMIC DISEASE, (3) TO CHARACTERIZE THE EARLY CATARACT IN EPIDEMIOLOGIC STUDIES OF POPULATIONS SUBJECT TO DIFFERENTIAL CATARACTOGENIC STRESS, AND (4) TO PROVIDE A QUANTITATIVE BASIS FOR THE DECISION TO INITIATE SURGICAL OR MEDICAL TREATMENT OF A CATARACT.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government